Project Details
Description
Phase I, First-Time-in-Human Study of MED/9197, a TLR 718 Agonist, Administered Intratumorally in Subjects with a Solid Tumor Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 9/8/15 → 7/30/20 |
Funding
- MEDIMMUNE, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.